Introduction
Angiolymphoid hyperplasia with eosinophilia (ALHE) is an uncommon idiopathic condition characterized by isolated or grouped papules, plaques, or nodules in the skin of the head and neck. ALHE is a benign neoplasm, but may be persistent and difficult to eradicate. It presents most commonly in patients aged 20-50 years and rarely in elderly people.
II. Case History
A 65 year-old man presented with a scalp nodule of 1 year duration on his left parietal area. His medical history was unremarkable. No abnormality was detected in general physical examination. Dermatological examination revealed an asymptomatic subcutaneous nodule of 2×1 cm in diameter in the left parietal region of the scalp. Excisional biopsy of the nodule was performed ( Figs. 1 and 2 ).Histopathologic examination of the skin biopsy specimen showed increased vascular proliferation, edematous endothelial cells and perivascular eosinophilic/lymphocytic infiltration. All routine laboratory investigations including whole blood count, sedimentation rate, renal and liver function tests,peripheral blood eosinophil counts were within normal limits. On the basis of clinical and histopathological features, the patient was diagnosed as having ALHE. The patient didn't come to regular follow-up examinations.
III. Discussion
Angiolymphoid hyperplasia with eosinophilia, first described by Wells and Whimster in 1969, is a rare benign vascular tumor. [1] It is characterized by one or more purplish, brownish papules and subcutaneous nodules with a predilection for the head and neck regions. Other tissues such as orbit, heart, bone, liver and spleen may also be involved. It is more common in middle-aged females. Contrary the name suggests, peripheral blood eosinophilia is not a constant finding in ALHE. [2] Histopathologically, ALHE is characterized by numerous thick and thin-walled vessels lined with characteristic edematous endothelial cells ("hobnail"or "tombstone" appearance) associated with variable lymphocytic and eosinophilic infi ltrate. [3] The etiopathogenesis of ALHE is not well known. Trauma, hormonal changes and infections (HTLV or HHV 8) have been suggested to play a role in the pathogenesis. Association of ALHE with nephritic syndrome and pregnancy have been described. [4, 5] Overexpression of estrogen and progesterone receptors was detected in pregnant women. [6] Interleukin 5 and vascular endothelial growth factor were also found to be increased in some cases. [7 ] The subcutaneous lesions associated with ALHE may vary in colour, shape and size. Ranging from red to brown in colour, the lesions may be smooth or centrally eroded with crusting. The size of a single lesion may vary from 0.2 to 8 cm, most commonly measuring 0.5-2 cm. Approximately 80% of patients demonstrate solitary lesions, while 20% have multiple lesions clustered in one area. They are most commonly seen in the peri-auricular area, forehead or scalp. Rare sites of involvement include the shoulders, hands,breasts and penis. ALHE tends to affect the skin and subcutaneous tissues, however, it has also been described in other tissues, such as the orbit, oral mucosa, liver, spleen, heart, bone and blood vessels. [8] Systemic eosinophilia of 6-34% is seen in 20% of patients. [9] Regional lymphadenopathy and arteriovenous shunts have occasionally been reported but are inconsistent features. Since they share many clinical and histopathological similarities, ALHE should be differentiated from Kimura's disease. Kimura's disease occurs in younger patients, the lesions show deeper localization and association with lymphadenopathy. Histologically, it contains sclerosis at any stage, but does not have epithelioid endothelial cells. ALHE rarely regresses spontaneously; however, malignant transformation does not occur. Several treatment modalities have been used, including intralesional corticosteroid injections, interferon α2b, cytotoxic agents,cryotherapy, electrodessication, pulse-dye laser and carbon dioxide laser. Surgical excisions that include the arterial and venous segments at the base of the lesion are most successful, with no reported recurrence after 1 year of follow-up. [10] 
